Accretion Nutraveda Board of Directors
Get the latest insights into the leadership at Accretion Nutraveda. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mayur Popatlal Sojitra | Managing Director |
| Ankurkumar Patel | Whole Time Director |
| Paraskumar Vinubhai Parmar | Executive Director & CFO |
| Hardik Mukundbhai Prajapati | Non Executive Director |
| Harshad Nanubhai Rathod | Non Executive Director |
| Vivek Ashok Kumar Patel | Non Executive Director |
| Arun Dash | Non Executive Independent Director |
| Mahipal Singh Chouhan | Non Executive Independent Director |
| Shruti Gupta | Non Executive Independent Director |
| Payal Hareshbhai Kotadiya | Company Secretary & Compliance Officer |
Accretion Nutraveda FAQs
The board at Accretion Nutraveda consists of experienced professionals, including Mayur Popatlal Sojitra, Ankurkumar Patel, and others, overseeing the company’s strategic and corporate governance.
Directors at Accretion Nutraveda are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mayur Popatlal Sojitra is the current chairman at Accretion Nutraveda.
Executive directors at Accretion Nutraveda are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Accretion Nutraveda adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Accretion Nutraveda, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
